Anaptysbio (ANAB) Equity Average (2017 - 2025)
Historic Equity Average for Anaptysbio (ANAB) over the last 9 years, with Q3 2025 value amounting to -$37.1 million.
- Anaptysbio's Equity Average fell 17867.6% to -$37.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.1 million, marking a year-over-year decrease of 17867.6%. This contributed to the annual value of $79.5 million for FY2024, which is 5460.64% down from last year.
- Anaptysbio's Equity Average amounted to -$37.1 million in Q3 2025, which was down 17867.6% from -$5.4 million recorded in Q2 2025.
- In the past 5 years, Anaptysbio's Equity Average ranged from a high of $389.3 million in Q1 2021 and a low of -$37.1 million during Q3 2025
- Moreover, its 5-year median value for Equity Average was $169.8 million (2023), whereas its average is $190.3 million.
- Per our database at Business Quant, Anaptysbio's Equity Average surged by 372.94% in 2021 and then crashed by 17867.6% in 2025.
- Anaptysbio's Equity Average (Quarter) stood at $370.0 million in 2021, then decreased by 27.07% to $269.9 million in 2022, then crashed by 61.37% to $104.2 million in 2023, then decreased by 25.54% to $77.6 million in 2024, then tumbled by 147.77% to -$37.1 million in 2025.
- Its Equity Average stands at -$37.1 million for Q3 2025, versus -$5.4 million for Q2 2025 and $52.4 million for Q1 2025.